Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahrokh Shariat

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
World Journal of Urology|June 13, 2020
Making a case "against" focal therapy for intermediate-risk prostate cancerPaolo Gontero, Giancarlo Marra, Dogu Teber, et al.
Pathology Oncology Research : POR|July 30, 2017
HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial CarcinomasKlaus Aumayr, Tobias Klatte, Barbara Neudert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2025
Genomic instability is associated with response to [¹⁷⁷Lu]Lu-PSMA-I&T radioligand therapy: an exploratory, preliminary liquid biopsy analysisKilian Kluge, David Haberl, Alexander Haug, et al.
Wiener Klinische Wochenschrift|March 31, 2015
Patient's and physician's behavior on the management of benign prostatic hyperplasia among the patients at the risk of clinical progression. A multicenter noninterventional trial in Slovakia by "Prostate and Expectations of Treatment: Epidemiology Research" (PETER) study groupPeter Weibl, Peter Laurinc, Roman Tomaškin, et al.
European Urology Oncology|November 16, 2024
Unmet Need in Non-muscle-invasive Bladder Cancer Failing Bacillus Calmette-Guérin Therapy: A Systematic Review and Cost-effectiveness Analyses from the International Bladder Cancer GroupDavid D'Andrea, Hugh Mostafid, Paolo Gontero, et al.
The Canadian Journal of Urology|March 22, 2005
Exploration of health-related quality of life areas that may distinguish between continent diversion and ileal conduit patientsAlvaro Ramirez, Paul Perrotte, Luc Valiquette, et al.
World Journal of Urology|April 21, 2018
Role of quantitative computed tomography texture analysis in the prediction of adherent perinephric fatZine-Eddine Khene, Karim Bensalah, Axel Largent, et al.
JMIR Research Protocols|February 4, 2020
Evaluation of Patterns of Presentation, Practice, and Outcomes of Upper Tract Urothelial Cancer: Protocol for an Observational, International, Multicenter, Cohort Study by the Clinical Research Office of the Endourology SocietyJoyce Baard, Merve Celebi, Jean de la Rosette, et al.
International Journal of Epidemiology|January 23, 2020
The impact of hormones and reproductive factors on the risk of bladder cancer in women: results from the Nurses' Health Study and Nurses' Health Study IIMohammad Abufaraj, Shahrokh Shariat, Marco Moschini, et al.
Future Oncology (London, England)|March 13, 2020
KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBCAshish M Kamat, Neal Shore, Noah Hahn, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
World Journal of Urology|June 13, 2020
Making a case "against" focal therapy for intermediate-risk prostate cancerPaolo Gontero, Giancarlo Marra, Dogu Teber, et al.
Pathology Oncology Research : POR|July 30, 2017
HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial CarcinomasKlaus Aumayr, Tobias Klatte, Barbara Neudert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2025
Genomic instability is associated with response to [¹⁷⁷Lu]Lu-PSMA-I&T radioligand therapy: an exploratory, preliminary liquid biopsy analysisKilian Kluge, David Haberl, Alexander Haug, et al.
Wiener Klinische Wochenschrift|March 31, 2015
Patient's and physician's behavior on the management of benign prostatic hyperplasia among the patients at the risk of clinical progression. A multicenter noninterventional trial in Slovakia by "Prostate and Expectations of Treatment: Epidemiology Research" (PETER) study groupPeter Weibl, Peter Laurinc, Roman Tomaškin, et al.
European Urology Oncology|November 16, 2024
Unmet Need in Non-muscle-invasive Bladder Cancer Failing Bacillus Calmette-Guérin Therapy: A Systematic Review and Cost-effectiveness Analyses from the International Bladder Cancer GroupDavid D'Andrea, Hugh Mostafid, Paolo Gontero, et al.
The Canadian Journal of Urology|March 22, 2005
Exploration of health-related quality of life areas that may distinguish between continent diversion and ileal conduit patientsAlvaro Ramirez, Paul Perrotte, Luc Valiquette, et al.
World Journal of Urology|April 21, 2018
Role of quantitative computed tomography texture analysis in the prediction of adherent perinephric fatZine-Eddine Khene, Karim Bensalah, Axel Largent, et al.
JMIR Research Protocols|February 4, 2020
Evaluation of Patterns of Presentation, Practice, and Outcomes of Upper Tract Urothelial Cancer: Protocol for an Observational, International, Multicenter, Cohort Study by the Clinical Research Office of the Endourology SocietyJoyce Baard, Merve Celebi, Jean de la Rosette, et al.
International Journal of Epidemiology|January 23, 2020
The impact of hormones and reproductive factors on the risk of bladder cancer in women: results from the Nurses' Health Study and Nurses' Health Study IIMohammad Abufaraj, Shahrokh Shariat, Marco Moschini, et al.
Future Oncology (London, England)|March 13, 2020
KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBCAshish M Kamat, Neal Shore, Noah Hahn, et al.
Pageof 10